Registration - In-house Corporation

Tetra Bio-Pharma Inc. / Guy Chamberland, Chief Executive Officer

Registration Information

In-house Corporation name: Tetra Bio-Pharma Inc.
Responsible Officer Name: Guy Chamberland, Chief Executive Officer
Initial registration start date: 2021-06-17
Registration status: Inactive
Registration Number: 949526-369802

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 1 (2021-06-17 to 2021-12-07)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Intellectual Property
Regional Development
Research and Development
Science and Technology

Subject Matter Details

Grant, Contribution or Other Financial Benefit

As part of the Strategic Innovation Fund program, for the strategic development of the Company, request for non-dilutive financial support such as grants, loans or other financial products to promote product development, promote investment in research and development (R&D) and promote investments to support the commercialization and industrialization of its products, such as drugs acting on the human endocannabinoid system, intended to treat the medical conditions of hyperinflammation and pain management. Amounts to be defined.

Communication Techniques

Written communication
Oral communication

Government Institutions

Business Development Bank of Canada (BDC)
Canada Economic Development for Quebec Regions
Export Development Canada (EDC)
Health Canada (HC)
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)

In-house Corporation Details

Description of activities

Tetra Bio-Pharma is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies.

Responsible officer name and position during the period of this registration

Guy Chamberland, Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
365 rue St-Jean, Suite 122
Longueuil, QC J4H 2X7
Canada

Telephone number: 833-977-7575

Parent Company Information

Tetra Bio-Pharma Inc. is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

Tetra Bio-Pharma Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Guy Chamberland, Chief Executive Officer | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Tetra Bio-Pharma Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Tetra Bio-Pharma Inc./	2021-06-17	2021-12-07

Tetra Bio-Pharma Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Tetra Bio-Pharma Inc. / Guy Chamberland, Chief Executive Officer

Registration Information

Associated Communications

Version 1 of 1 (2021-06-17 to 2021-12-07)

Version 1 of 1 (2021-06-17 to 2021-12-07)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Registration - In-house Corporation

Tetra Bio-Pharma Inc. / Guy Chamberland, Chief Executive Officer

Version 1 of 1 (2021-06-17 to 2021-12-07)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Tetra Bio-Pharma Inc./

The following names have been used on or after July 2, 2008

Tetra Bio-Pharma Inc.

Guy Chamberland, Chief Executive Officer (Corporation)